Manufacturing Facilities

World’s largest cGMP API and Intermediates manufacturing facility.

MANUFACTURING FACILITIES

World’s largest cGMP API and Intermediates manufacturing facility.

Divi’s currently operates two manufacturing sites near Hyderabad and Visakhapatnam in India. A third manufacturing site is proposed to be set up near Kakinada, India in 2021.
Both the manufacturing units have more than 64 production buildings and 70 pharma suits with a total reaction capacity of more than ~14,500m3, making it one of the largest API manufacturing facilities in the world.
The pilot plants at Divi’s are capable of handling high potent products (Products with exposure level up to 10mcg/m3) and several low dose products under cGMP.
Divis is Commercial-scale manufacturer of non-potent & highly potent APIs to deliver from gram scale to 1000’s of tons under cGMP.
Divi’s pharma areas comply with class 100, 000 clean air requirement and each pharma will have suitable filtration and drying equipment like centrifuge, ANFD, VTDR, RCVD, milling and sieving equipment’s.
KILO-LABS

KILO LABS

  • Kilo Lab (cGMP)
  • Flexible, Multi-purpose
  • Scale-up studies
  • Production of Kgs to 00s of Kgs scale
Pilot-Plants

PILOT PLANTS

  • Physical segregation and containment for processing and isolation
  • Containment systems are in place to handle the hazardous reactions
  • All pilot plants are equipped with cryogenic, high temperature and high vacuum capabilities and offer a broad range of isolation equipment
Active-Pharmaceutical-Ingredient-Commercial-Scale

COMMERCIAL SCALE

  • Multipurpose production facilities offering greater flexibility
  • Special Production Blocks to handle pyrophoric reactions, high energetic, Azide chemistry, High Pressure  with fool proof safety requirements
  • Batch sizes as large as 6 MT

Manufacturing Plants Overview

Larget-AP-Manufacturing-Facility

UNIT-1

Total Land: 500 Acres (2 sq. kms)
CAPACITY : ~4000m3

Manufacturing Facility Near Hyderabad

INFRASTRUCTURE:

  • Land : 500 Acres (2 sq. kms)
  • Buildings : 13

CAPACITY:

  • Reactors : Over 700
  • Capacity: ~ 4500 m3

REGULATORY INSPECTIONS:

  • USFDA
  • EU GMP
  • JAPAN PMDA
  • MFDS(K FDA)
  • COFEPRIS
API-Company-in-Hyderabad

UNIT-II

Total Land: 500 Acres (2 sq. kms)
CAPACITY : ~10000m3

Manufacturing Facility Near Visakhapatnam

INFRASTRUCTURE:

  • Land : 500 Acres (1.8 sq. kms)
  • Buildings : 22

CAPACITY:

  • Reactors : 1100
  • Capacity: ~ 10000 m3

REGULATORY INSPECTIONS:

  • USFDA
  • MHRA (UK)
  • JAPAN PMDA
  • MFDS(Koriea FDA)
  • COFEPRIS
  • TGA (Australia)
Largest-Pharma-Manufacturing-Company

UNIT-III

Total Land:  425 Acres (1.2 sq. kms) 
CAPACITY  : Construction  under progress

Manufacturing Facility Near Kakinada (Under progress)

2019:

Setting up of Unit – III Manufacturing Site at Kakinada